Genomic sequencing is yielding critical insights into how th...
Read More The U.K.’s Ambitious Test-and-Sequence Strategy Aims to Block Emerging COVID-19 StrainsRapid Genetic Sequencing for COVID-19 Global Surveillance
With more strains of SARS-CoV-2 appearing in communities acr...
Read More Rapid Genetic Sequencing for COVID-19 Global SurveillanceNecessity of Sequencing Emerging SARS-CoV-2 Variants from UK and...
With the emergence of the new B.1.1.7 (UK) and B.1.351 (Sout...
Read More Necessity of Sequencing Emerging SARS-CoV-2 Variants from UK and S. AfricaPodcast: Benefits of Targeted NGS for SARS-CoV-2 Epidemiology an...
While molecular methods like quantitative polymerase chain r...
Read More Podcast: Benefits of Targeted NGS for SARS-CoV-2 Epidemiology and Lessons LearnedTargeted NGS Reveals Two Distinct Immune Responses to SARS-CoV-2...
Emerging biomarkers of immune responses to SARS-CoV-2 infect...
Read More Targeted NGS Reveals Two Distinct Immune Responses to SARS-CoV-2 Infection from Postmortem Lung TissueSequencing dominant SARS-CoV-2 strain in suburban, southern U.S....
While many technologies can be used to determine presence or...
Read More Sequencing dominant SARS-CoV-2 strain in suburban, southern U.S. regionUsing Next-Generation Sequencing to Identify SARS-CoV-2 Transmis...
While standard PCR testing can determine whether a sample is...
Read More Using Next-Generation Sequencing to Identify SARS-CoV-2 Transmission ChainsTargeted NGS or Serology for SARS-CoV-2 Epidemiology Research?
Mapping out the spread SARS-CoV-2 virus to determine if new ...
Read More Targeted NGS or Serology for SARS-CoV-2 Epidemiology Research?Cytokines May Be An Indication Of Susceptibility To SARS-CoV-2
Adverse events from SARS-CoV-2 infection may be due to an ov...
Read More Cytokines May Be An Indication Of Susceptibility To SARS-CoV-2Spotlight: La Paz University Hospital in fight against SARS-CoV-...
La Paz University Hospital (HULP) is a public hospital in Sp...
Read More Spotlight: La Paz University Hospital in fight against SARS-CoV-2